Literature DB >> 19122029

Frontal FDG-PET activity correlates with cognitive outcome after STN-DBS in Parkinson disease.

E Kalbe1, J Voges, T Weber, M Haarer, S Baudrexel, J C Klein, J Kessler, V Sturm, W D Heiss, R Hilker.   

Abstract

BACKGROUND: Inconsistent changes of cognitive functioning have been reported in patients with Parkinson disease (PD) with deep brain stimulation (DBS) of the subthalamic nucleus (STN). To investigate the underlying pathomechanisms, we correlated alterations of cognitive test performance and changes of neuronal energy metabolism in frontal basal ganglia projection areas under bilateral STN stimulation.
METHODS: We conducted verbal fluency, learning, and memory tests and 18-fluorodeoxyglucose (FDG) PET in nine patients with PD with STN-DBS before and 6 months after surgery. Using coregistered MRI, postoperative changes of the normalized cerebral metabolic rates of glucose (nCMRGlc) in the dorsolateral prefrontal cortex (DLPFC), lateral orbitofrontal cortex (LOFC), ventral and dorsal cingulum (v/dACC), and in Broca area were determined and correlated with alterations of neuropsychological test results.
RESULTS: After surgery, highly variable changes of both cognitive test performance and frontal nCMRGlc values were found with significant correlations between verbal fluency and FDG uptake in the left DLPFC (Brodmann area [BA] 9, 46), left Broca area (BA 44/45), and the right dACC (BA 32). A decrease of nCMRGlc in the left OFC (BA 11/47) and dACC (BA 32) correlated with a decline of verbal learning. All patients showed reduced metabolic activity in the right anterior cingulate cortex after DBS. Baseline cognitive abilities did not predict verbal learning or fluency changes after surgery.
CONCLUSIONS: These data show a significant linear relationship between changes in frontal 18-fluorodeoxyglucose PET activity and changes in cognitive outcome after deep brain stimulation of the subthalamic nucleus (STN) in advanced Parkinson disease. The best correlations were found in the left frontal lobe (dorsolateral prefrontal cortex and Broca area). Baseline performance on cognitive tests did not predict cognitive or metabolic changes after STN electrode implantation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19122029     DOI: 10.1212/01.wnl.0000338536.31388.f0

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  39 in total

1.  Subthalamic nucleus stimulation affects limbic and associative circuits: a PET study.

Authors:  Florence Le Jeune; Julie Péron; Didier Grandjean; Sophie Drapier; Claire Haegelen; Etienne Garin; Bruno Millet; Marc Vérin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-03-28       Impact factor: 9.236

Review 2.  Network effects of deep brain stimulation.

Authors:  Ahmad Alhourani; Michael M McDowell; Michael J Randazzo; Thomas A Wozny; Efstathios D Kondylis; Witold J Lipski; Sarah Beck; Jordan F Karp; Avniel S Ghuman; R Mark Richardson
Journal:  J Neurophysiol       Date:  2015-08-12       Impact factor: 2.714

Review 3.  What is the best treatment for fluctuating Parkinson's disease: continuous drug delivery or deep brain stimulation of the subthalamic nucleus?

Authors:  Rüdiger Hilker; Angelo Antonini; Per Odin
Journal:  J Neural Transm (Vienna)       Date:  2010-12-25       Impact factor: 3.575

4.  A 5-year prospective assessment of advanced Parkinson disease patients treated with subcutaneous apomorphine infusion or deep brain stimulation.

Authors:  Angelo Antonini; Ioannis U Isaias; Giorgia Rodolfi; Andrea Landi; Francesca Natuzzi; Chiara Siri; Gianni Pezzoli
Journal:  J Neurol       Date:  2010-10-23       Impact factor: 4.849

5.  EEG power asymmetry and functional connectivity as a marker of treatment effectiveness in DBS surgery for depression.

Authors:  Maher A Quraan; Andrea B Protzner; Zafiris J Daskalakis; Peter Giacobbe; Chris W Tang; Sidney H Kennedy; Andres M Lozano; Mary P McAndrews
Journal:  Neuropsychopharmacology       Date:  2013-11-28       Impact factor: 7.853

Review 6.  The role of the subthalamic nucleus in cognition.

Authors:  David B Weintraub; Kareem A Zaghloul
Journal:  Rev Neurosci       Date:  2013       Impact factor: 4.353

7.  Dissociable dorsal and ventral frontostriatal working memory circuits: evidence from subthalamic stimulation in Parkinson's disease.

Authors:  Jocelyne Ventre-Dominey; Stéphanie Bourret; Hélène Mollion; Emmanuel Broussolle; Peter Ford Dominey
Journal:  Hum Brain Mapp       Date:  2012-10-25       Impact factor: 5.038

8.  Subthalamic nucleus deep brain stimulation induces motor network BOLD activation: use of a high precision MRI guided stereotactic system for nonhuman primates.

Authors:  Hoon-Ki Min; Erika K Ross; Kendall H Lee; Kendall Dennis; Seong Rok Han; Ju Ho Jeong; Michael P Marsh; Bryan Striemer; Joel P Felmlee; J Luis Lujan; Steve Goerss; Penelope S Duffy; Charles Blaha; Su-Youne Chang; Kevin E Bennet
Journal:  Brain Stimul       Date:  2014-05-02       Impact factor: 8.955

9.  Subthalamic nucleus involvement in executive functions with increased cognitive load: a subthalamic nucleus and anterior cingulate cortex depth recording study.

Authors:  Stefania Rusnáková Aulická; Pavel Jurák; Jan Chládek; Pavel Daniel; Josef Halámek; Marek Baláž; Martina Bočková; Jan Chrastina; Ivan Rektor
Journal:  J Neural Transm (Vienna)       Date:  2014-03-23       Impact factor: 3.575

10.  Low Cerebral Glucose Metabolism: A Potential Predictor for the Severity of Vascular Parkinsonism and Parkinson's Disease.

Authors:  Yunqi Xu; Xiaobo Wei; Xu Liu; Jinchi Liao; Jiaping Lin; Cansheng Zhu; Xiaochun Meng; Dongsi Xie; Dongman Chao; Albert J Fenoy; Muhua Cheng; Beisha Tang; Zhuohua Zhang; Ying Xia; Qing Wang
Journal:  Aging Dis       Date:  2015-11-17       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.